141 related articles for article (PubMed ID: 7690322)
1. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14.
Labeta MO; Durieux JJ; Fernandez N; Herrmann R; Ferrara P
Eur J Immunol; 1993 Sep; 23(9):2144-51. PubMed ID: 7690322
[TBL] [Abstract][Full Text] [Related]
2. The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes.
Durieux JJ; Vita N; Popescu O; Guette F; Calzada-Wack J; Munker R; Schmidt RE; Lupker J; Ferrara P; Ziegler-Heitbrock HW
Eur J Immunol; 1994 Sep; 24(9):2006-12. PubMed ID: 7522157
[TBL] [Abstract][Full Text] [Related]
3. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants.
Bufler P; Stiegler G; Schuchmann M; Hess S; Krüger C; Stelter F; Eckerskorn C; Schütt C; Engelmann H
Eur J Immunol; 1995 Feb; 25(2):604-10. PubMed ID: 7533093
[TBL] [Abstract][Full Text] [Related]
4. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes.
Couturier C; Jahns G; Kazatchkine MD; Haeffner-Cavaillon N
Eur J Immunol; 1992 Jun; 22(6):1461-6. PubMed ID: 1376258
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
Golenbock DT; Bach RR; Lichenstein H; Juan TS; Tadavarthy A; Moldow CF
J Lab Clin Med; 1995 May; 125(5):662-71. PubMed ID: 7537790
[TBL] [Abstract][Full Text] [Related]
6. Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages.
Landmann R; Ludwig C; Obrist R; Obrecht JP
J Cell Biochem; 1991 Dec; 47(4):317-29. PubMed ID: 1724447
[TBL] [Abstract][Full Text] [Related]
7. Moesin: a potential LPS receptor on human monocytes.
Amar S; Oyaisu K; Li L; Van Dyke T
J Endotoxin Res; 2001; 7(4):281-6. PubMed ID: 11717582
[TBL] [Abstract][Full Text] [Related]
8. CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis.
Labeta MO; Durieux JJ; Spagnoli G; Fernandez N; Wijdenes J; Herrmann R
Immunology; 1993 Nov; 80(3):415-23. PubMed ID: 7507090
[TBL] [Abstract][Full Text] [Related]
9. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ
J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085
[TBL] [Abstract][Full Text] [Related]
10. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide.
Vita N; Lefort S; Sozzani P; Reeb R; Richards S; Borysiewicz LK; Ferrara P; Labéta MO
J Immunol; 1997 Apr; 158(7):3457-62. PubMed ID: 9120307
[TBL] [Abstract][Full Text] [Related]
11. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors.
Gessani S; Testa U; Varano B; Di Marzio P; Borghi P; Conti L; Barberi T; Tritarelli E; Martucci R; Seripa D
J Immunol; 1993 Oct; 151(7):3758-66. PubMed ID: 7690813
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages.
Dentener MA; Bazil V; Von Asmuth EJ; Ceska M; Buurman WA
J Immunol; 1993 Apr; 150(7):2885-91. PubMed ID: 7681082
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide.
Haziot A; Tsuberi BZ; Goyert SM
J Immunol; 1993 Jun; 150(12):5556-65. PubMed ID: 7685797
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N
Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
[TBL] [Abstract][Full Text] [Related]
16. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood.
Haziot A; Rong GW; Bazil V; Silver J; Goyert SM
J Immunol; 1994 Jun; 152(12):5868-76. PubMed ID: 7515917
[TBL] [Abstract][Full Text] [Related]
17. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.
Heumann D; Gallay P; Barras C; Zaech P; Ulevitch RJ; Tobias PS; Glauser MP; Baumgartner JD
J Immunol; 1992 Jun; 148(11):3505-12. PubMed ID: 1375247
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
Leeuwenberg JF; Dentener MA; Buurman WA
J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
[TBL] [Abstract][Full Text] [Related]
19. sCD14 prevents endotoxin inducible oxidative burst response of human monocytes.
Schütt C; Schilling T; Krüger C
Allerg Immunol (Leipz); 1991; 37(3-4):159-64. PubMed ID: 1724353
[TBL] [Abstract][Full Text] [Related]
20. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers.
Espevik T; Otterlei M; Skjåk-Braek G; Ryan L; Wright SD; Sundan A
Eur J Immunol; 1993 Jan; 23(1):255-61. PubMed ID: 7678226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
